These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 8628887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [Abstract] [Full Text] [Related]

  • 3. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E, Cariello G, Barile A, Sabatini M, Michelini O, Erriquez D, Masciocchi C.
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
    Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H.
    Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
    Mahfouz AE, Hamm B, Taupitz M, Wolf KJ.
    Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D.
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [Abstract] [Full Text] [Related]

  • 9. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ, Schwarz W, Hammerstingl R, Kümmel S, Balzer JO, Mack MG, Diebold T, Balzer T, Shamsi K, Bechstein WO, Schrem H, Neuhaus P, Felix R.
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [Abstract] [Full Text] [Related]

  • 10. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
    Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, Kako N, Matsunaga N, Hoshi H, Shiraishi J.
    AJR Am J Roentgenol; 2001 Sep; 177(3):637-43. PubMed ID: 11517061
    [Abstract] [Full Text] [Related]

  • 11. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R.
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [Abstract] [Full Text] [Related]

  • 12. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S, Edelman RR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF.
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [Abstract] [Full Text] [Related]

  • 13. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
    Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J.
    J Comput Assist Tomogr; 1995 May; 19(3):412-8. PubMed ID: 7790551
    [Abstract] [Full Text] [Related]

  • 14. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT.
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [Abstract] [Full Text] [Related]

  • 15. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM, Kim CS, Youk JH, Lee MS.
    Korean J Radiol; 2003 May; 4(1):9-18. PubMed ID: 12679629
    [Abstract] [Full Text] [Related]

  • 16. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR, Mergo PJ, Torres GM, Ros PR.
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P, Steiner P, Schoder V, Dieckmann C, Kuhlencordt R, Adam G.
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.